Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous...
Transcript of Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous...
![Page 1: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/1.jpg)
![Page 2: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/2.jpg)
Chromoblastomycosisversus Phaeohyphomycosis
Facultat de Medicina i Ciències de la Salut
Unitat de Microbiologia
Universitat Rovira i Virgili
Reus (Spain)
Emilio Mayayo, Enrique Calvo and Josep Guarro
![Page 3: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/3.jpg)
CHROMOBLASTOMYCOSIS
• Cutaneous and subcutaneous chronic infectioncaused by the traumatic inoculation of adematiaceous fungus.
• No death, incapacitating and deforming
• Described at five continents (tropicals andsubtropicals), is comun in Venezuela, Brasil,Mexico and Central-America
![Page 4: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/4.jpg)
Diagnosis
Direct examination (warty nodules)
Clinical characteristics as: development of nodular lesions which can progress
over years to irregular verrucose hyperkeratotic forms, scaly plaques or cicatricial
atrophic skin lesions
![Page 5: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/5.jpg)
![Page 6: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/6.jpg)
![Page 7: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/7.jpg)
![Page 8: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/8.jpg)
Diagnosis
Culture
Histology (presence of muriform cells or Medlar bodies)
![Page 9: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/9.jpg)
Main fungi causing the disease
• Fonsecaea pedrosoi, Cladophialophora carrionii,
Phialophora verrucosa, Rhinocladiella aquaspersa
• Exophiala jeanselmei, Exophiala spinifera, Exophiala dermatitidis
• Cladophialophora bopii
![Page 10: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/10.jpg)
Objetives:
• To establish a chronic murine model ofchromoblastomycosis
• To observe the cyto-histological patterns and responseon tissue
• To compare the evolution of the infection after theadministration of new generation treatments(posaconazole and voriconazole) in front of therecommended therapies (itraconazole and terbinafine)
![Page 11: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/11.jpg)
Model establishment
• IMMUNOCOMP. IV ACUTE INFECTION
• IMMUNOSUP. IV ACUTE INFECTION(CORTISONE)
• INMUNOCOMP. SC ACUTE INFECTION
• IMMUNOSUP. SC CHRONIC INFECTION(ATHIMICS)
• INMUNOCOMP. IP ACUTE INFECTION(LACTANTES)
• INMUNOCOMP. IP CHRONIC INFECTION
INOCULA 1x105-1x108 cfu/mL
Cardona-Castro et al. 1999. Med. Mycol. 37:81-83
Mice Inf. route Response
![Page 12: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/12.jpg)
Materials & Methods
• Strains: F. pedrosoi: FMR 5211, FMR 6630P. verrucosa FMR 5210
• Mice: Cd1/nude (athimics)
• Ceftazidime: 0.05 mL (150mg/kg) s.c.
• Anesthetic: isoflurane
• Infection: 0.1 ml s.c. 3x107 cfu/ml
![Page 13: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/13.jpg)
Subcutaneous infection in nude mice
![Page 14: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/14.jpg)
F. pedrosoi 6630
F. pedrosoi 5211
P. verrucosa 5210
![Page 15: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/15.jpg)
12 weeks post-infection strain FMR 6630
![Page 16: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/16.jpg)
Materials & methods
• Treatments: (3 weeks after the infection)
– Posaconazol 10, 20 mg/kg/day (orally)
– Voriconazol 10, 20 mg/kg/day (orally)
– Itraconazol 25, 50 mg/kg/day (orally)
– Terbinafine 150, 250 mg/kg/day (orally)
![Page 17: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/17.jpg)
MICs ( g/ml)
PSC VRC ITZ TRB
6630 0.12 0.12 0.5 0.12
In vitro activities of antifungal drugs
against the isolate F.pedrosoi FMR 6630
![Page 18: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/18.jpg)
Materials & methods
• Lesions were measured at 3 weeks intervals
![Page 19: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/19.jpg)
Culture
At the end of the therapy skin lesions were cultured
![Page 20: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/20.jpg)
![Page 21: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/21.jpg)
Histology
![Page 22: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/22.jpg)
![Page 23: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/23.jpg)
Results:
Control group
CONTROL
0
2
4
6
8
10
12
14
16
0 3 6 9 12
weeks
mm
2 CONTROL
![Page 24: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/24.jpg)
POSACONAZOLE
0
2
4
6
8
10
12
14
16
0 3 6 9 12
weeks
mm
2
CONTROL
PSC 10
PSC 20
![Page 25: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/25.jpg)
VORICONAZOLE
0
2
4
6
8
10
12
14
16
18
20
0 3 6 9 12
weeks
mm
2
CONTROL
VRC 10
VRC 20
![Page 26: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/26.jpg)
ITRACONAZOLE
0
2
4
6
8
10
12
14
16
0 3 6 9 12
weeks
mm
2
CONTROL
ITZ 25
ITZ 50
![Page 27: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/27.jpg)
TERBINAFINE
0
2
4
6
8
10
12
14
16
0 3 6 9 12
weeks
mm
2
CONTROL
TRB 150
TRB 200
![Page 28: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/28.jpg)
Group 1 Group 2
Mann Whitney
p-value **
Control ITZ 25 0.222
Control ITZ 50 0.009
Control PSC 10 0.076
Control PSC 20 0.009
Control TRB 150 0.117
Control TRB 250 0.047
Control VRC 10 0.917
Control VRC 20 0.222
ITZ 25 ITZ 50 0.347
PSC 10 PSC 20 0.028
TRB 150 TRB 250 0.602
VRC 10 VRC 20 0.302
Kruskal-Wallis p-value * = 0.016
* K muestras independientes
** 2 muestras independientes
![Page 29: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/29.jpg)
Groups
Increase in the
lesions
after 12 weeks
(%)
Positive
cultures (%)
CONTROL +82.6 100
ITZ 25 +23.9 100
ITZ 50 -24.3 80
PSC 10 -23.8 60
PSC 20 -69.6 40
TRB 150 +13.7 100
TRB 250 -0.6 100
VRC 10 +84.2 100
VRC 20 +10.5 100
![Page 30: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/30.jpg)
Conclusions
• Cytopathological studies are neccesary.
• The results confirm PSC as an alternative in the
treatment of chromoblastomycosis. However, its
elevate cost would limit its use to cases in which
therapies with ITZ and TRB were not completely
successful.
• VRC showed modest results and its efficacy in this
kind of infections seems to be poor.
![Page 31: Chromoblastomycosis versus Phaeohyphomycosis · 2012. 7. 13. · CHROMOBLASTOMYCOSIS •Cutaneous and subcutaneous chronic infection caused by the traumatic inoculation of a dematiaceous](https://reader035.fdocuments.us/reader035/viewer/2022071505/6125cb344ac649595816a1fd/html5/thumbnails/31.jpg)
¡MUCHAS
GRACIAS!
THANK YOU!